Association of VEGF With Antianhedonic Effects of Repeated-Dose Intravenous Ketamine in Treatment-Refractory Depression.

Zheng, Wei; Gu, Li-Mei; Zhou, Yan-Ling; Wang, Cheng-Yu; Lan, Xiao-Feng; Zhang, Bin; Shi, Hai-Shan; Wang, Dan-Feng; Ning, Yu-Ping

Zheng, Wei; Gu, Li-Mei; Zhou, Yan-Ling; Wang, Cheng-Yu; Lan, Xiao-Feng; Zhang, Bin; Shi, Hai-Shan; Wang, Dan-Feng; Ning, Yu-Ping.

Afiliação

Zheng W; The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China.
Gu LM; The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China.
Zhou YL; The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China.
Wang CY; The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China.
Lan XF; The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China.
Zhang B; The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China.
Shi HS; The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China.
Wang DF; The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China.
Ning YP; The Affiliated Brain Hospital of Guangzhou Medical University (Guangzhou Huiai Hospital), Guangzhou, China.

Front Psychiatry ; 12: 780975, 2021.

Article em En | MEDLINE | ID: mdl-34925104

Palavras-chave

VEGF; antianhedonic effect; ketamine; major depressive disorder; response

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Front Psychiatry Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China País de publicação: Suíça

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google